Return To Office: Pfizer To Enforce 2-3 Days In Office Starting January

Vandana Singh
1 min read
8
In this article:

  • Pfizer Inc's (NYSE: PFE) CEO Albert Bourla said the U.S. employees would have to return to their workplaces two to three days a week starting in January.

  • About one-third of Pfizer's employees have still not returned to the office as concerns about the pandemic have begun fading, Bourla said in a panel discussion at the Paley International Council Summit in New York.

  • Pfizer joined forces with BioNTech SE (NASDAQ: BNTX) to develop one of the first COVID-19 vaccines at top speed during the pandemic when many employees were working from home and then generated the Paxlovid pill for treating people at high risk of severe disease.

  • Both products have been highly successful for the company.

  • Related: Pfizer's Q3 Earnings Surpasses Estimates, Lifts Forecasts For COVID-19 Vaccine Sales By $2B.

  • "I started to worry we were going to lose the DNA of our company, the feeling of family," Bourla said in the discussion. "For our workforce, people with office-type jobs, we are asking them, and will start enforcing a two to three days" of weekly attendance, he said.

  • "We're trying to see how we can play our cards so that we can save the world once again," Bourla said.

  • Price Action: PFE shares are down 0.55% at $47.09 during the premarket session on the last check Wednesday.

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Advertisement

Recommended Stories